ARMS is often characterized by the presence of a fusion oncoprotein, namely paired box 3-forkhead Box O1 (PAX3-FOXO1) or PAX7-FOXO1 and it is clinically more aggressive than ERMS (102). Here, FOXO1 is linked to alveolar rhabdomyosarcoma.